Published in J Biol Chem on March 24, 2013
The myokine irisin increases cortical bone mass. Proc Natl Acad Sci U S A (2015) 1.54
Follicle-Stimulating Hormone Increases the Risk of Postmenopausal Osteoporosis by Stimulating Osteoclast Differentiation. PLoS One (2015) 0.84
Morphological and histological adaptation of muscle and bone to loading induced by repetitive activation of muscle. Proc Biol Sci (2014) 0.83
Effects of low intensity vibration on bone and muscle in rats with spinal cord injury. Osteoporos Int (2014) 0.81
Multiple organ dysfunction and systemic inflammation after spinal cord injury: a complex relationship. J Neuroinflammation (2016) 0.75
Muscle Decline in Aging and Neuromuscular Disorders - Mechanisms and Countermeasures: Terme Euganee, Padova (Italy), April 13-16, 2016. Eur J Transl Myol (2016) 0.75
Reactions of the rat musculoskeletal system to compressive spinal cord injury (SCI) and whole body vibration (WBV) therapy. J Musculoskelet Neuronal Interact (2015) 0.75
Mice with sclerostin gene deletion are resistant to the severe sublesional bone loss induced by spinal cord injury. Osteoporos Int (2016) 0.75
Effect of recent spinal cord injury on the OPG/RANKL system and its relationship with bone loss and the response to denosumab therapy. Osteoporos Int (2017) 0.75
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (2001) 414.27
Bioconductor: open software development for computational biology and bioinformatics. Genome Biol (2004) 143.19
Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res (1987) 24.27
lumi: a pipeline for processing Illumina microarray. Bioinformatics (2008) 17.19
Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Dev Cell (2005) 7.64
c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling. Science (1994) 5.97
Leptin regulates bone formation via the sympathetic nervous system. Cell (2002) 5.95
Matrix-embedded cells control osteoclast formation. Nat Med (2011) 5.77
Mechanical stimulation of bone in vivo reduces osteocyte expression of Sost/sclerostin. J Biol Chem (2007) 4.74
FSH directly regulates bone mass. Cell (2006) 4.64
TSH is a negative regulator of skeletal remodeling. Cell (2003) 4.34
Skeletal remodeling in health and disease. Nat Med (2007) 4.31
Canonical WNT signaling promotes osteogenesis by directly stimulating Runx2 gene expression. J Biol Chem (2005) 3.97
Sclerostin mediates bone response to mechanical unloading through antagonizing Wnt/beta-catenin signaling. J Bone Miner Res (2009) 3.69
Osteocytes, mechanosensing and Wnt signaling. Bone (2008) 3.57
Wnt5a-Ror2 signaling between osteoblast-lineage cells and osteoclast precursors enhances osteoclastogenesis. Nat Med (2012) 3.46
MEF2C transcription factor controls chondrocyte hypertrophy and bone development. Dev Cell (2007) 2.96
Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease. Endocr Rev (2007) 2.82
Sclerostin stimulates osteocyte support of osteoclast activity by a RANKL-dependent pathway. PLoS One (2011) 2.10
The role of Dickkopf-1 in bone development, homeostasis, and disease. Blood (2008) 2.05
Increased sclerostin serum levels associated with bone formation and resorption markers in patients with immobilization-induced bone loss. J Clin Endocrinol Metab (2010) 1.98
Sost downregulation and local Wnt signaling are required for the osteogenic response to mechanical loading. Bone (2011) 1.96
Control of the SOST bone enhancer by PTH using MEF2 transcription factors. J Bone Miner Res (2007) 1.74
Neutralisation of Dkk-1 protects from systemic bone loss during inflammation and reduces sclerostin expression. Ann Rheum Dis (2010) 1.67
Bone-muscle strength indices for the human lower leg. Bone (2000) 1.65
Leptin and the sympathetic connection of fat to bone. Osteoporos Int (2007) 1.61
Adaptation of the proximal femur to skeletal reloading after long-duration spaceflight. J Bone Miner Res (2006) 1.55
Wnt signaling in bone metabolism. J Bone Miner Metab (2009) 1.48
Oxytocin is an anabolic bone hormone. Proc Natl Acad Sci U S A (2009) 1.44
Assessment of autonomic dysfunction following spinal cord injury: rationale for additions to International Standards for Neurological Assessment. J Rehabil Res Dev (2007) 1.39
Central control of bone remodeling by neuromedin U. Nat Med (2007) 1.32
Unloading induces osteoblastic cell suppression and osteoclastic cell activation to lead to bone loss via sympathetic nervous system. J Biol Chem (2005) 1.27
Muscle and bone plasticity after spinal cord injury: review of adaptations to disuse and to electrical muscle stimulation. J Rehabil Res Dev (2008) 1.26
From mechanostat theory to development of the "Functional Muscle-Bone-Unit". J Musculoskelet Neuronal Interact (2005) 1.25
Bone and muscle loss after spinal cord injury: organ interactions. Ann N Y Acad Sci (2010) 1.22
Inhibiting activin-A signaling stimulates bone formation and prevents cancer-induced bone destruction in vivo. J Bone Miner Res (2010) 1.18
Skeletal muscle hypertrophy and muscle myostatin reduction after resistive training in stroke survivors. Stroke (2010) 1.15
Regulatory mechanism of osteoclastogenesis by RANKL and Wnt signals. Front Biosci (Landmark Ed) (2011) 1.14
Growth differentiation factor 11 signals through the transforming growth factor-beta receptor ALK5 to regionalize the anterior-posterior axis. EMBO Rep (2006) 1.13
Up-regulation of the ectodermal-neural cortex 1 (ENC1) gene, a downstream target of the beta-catenin/T-cell factor complex, in colorectal carcinomas. Cancer Res (2001) 1.12
Prostaglandin E2: from clinical applications to its potential role in bone- muscle crosstalk and myogenic differentiation. Recent Pat Biotechnol (2012) 1.10
Parathyroid hormone induces c-fos promoter activity in osteoblastic cells through phosphorylated cAMP response element (CRE)-binding protein binding to the major CRE. J Biol Chem (1996) 1.08
Skeletal muscle secreted factors prevent glucocorticoid-induced osteocyte apoptosis through activation of β-catenin. Eur Cell Mater (2012) 1.06
Transcriptional regulation of bone and joint remodeling by NFAT. Immunol Rev (2010) 1.06
Elevated tumor necrosis factor-alpha in skeletal muscle after stroke. Stroke (2005) 1.03
Regulation of RANKL-induced osteoclastogenesis by TGF-β through molecular interaction between Smad3 and Traf6. J Bone Miner Res (2011) 0.97
REDD1 is a major target of testosterone action in preventing dexamethasone-induced muscle loss. Endocrinology (2009) 0.96
Evolving concepts in neurogenic osteoporosis. Curr Osteoporos Rep (2010) 0.95
The Wnt5a/Ror2 noncanonical signaling pathway inhibits canonical Wnt signaling in K562 cells. Int J Mol Med (2010) 0.95
Anabolic steroids reduce spinal cord injury-related bone loss in rats associated with increased Wnt signaling. J Spinal Cord Med (2013) 0.95
Early response of bone marrow osteoprogenitors to skeletal unloading and sclerostin antibody. Calcif Tissue Int (2012) 0.93
Protection against dexamethasone-induced muscle atrophy is related to modulation by testosterone of FOXO1 and PGC-1α. Biochem Biophys Res Commun (2010) 0.92
The effect of reloading on bone volume, osteoblast number, and osteoprogenitor characteristics: studies in hind limb unloaded rats. Bone (2005) 0.91
Changes induced in growing rat bone by immobilization and remobilization. Bone (1991) 0.88
Rat tail suspension reduces messenger RNA level for growth factors and osteopontin and decreases the osteoblastic differentiation of bone marrow stromal cells. J Bone Miner Res (1995) 0.87
Differential alterations in gene expression profiles contribute to time-dependent effects of nandrolone to prevent denervation atrophy. BMC Genomics (2010) 0.85
Bone response to normal weight bearing after a period of skeletal unloading. Am J Physiol (1989) 0.85
The effect of immobilization on the torsional strength of the rat tibia. Clin Orthop Relat Res (1993) 0.83
Nandrolone normalizes determinants of muscle mass and fiber type after spinal cord injury. J Neurotrauma (2012) 0.83
Down-regulation of the Wnt, estrogen receptor, insulin-like growth factor-I, and bone morphogenetic protein pathways in osteoblasts from rats with chronic spinal cord injury. Joint Bone Spine (2011) 0.81
The effect of remobilisation on the extremity of the adult rat after short-term immobilisation in a plaster cast. Acta Chir Scand Suppl (1976) 0.76
In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: determination of a pharmacokinetic/pharmacodynamic relationship. Clin Cancer Res (2003) 9.92
Reversing established sepsis with antagonists of endogenous high-mobility group box 1. Proc Natl Acad Sci U S A (2003) 7.14
The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J Exp Med (2005) 6.86
FSH directly regulates bone mass. Cell (2006) 4.64
TSH is a negative regulator of skeletal remodeling. Cell (2003) 4.34
Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance. Lancet (2013) 3.83
A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release. Proc Natl Acad Sci U S A (2010) 3.80
Mitochondrial transfer from bone-marrow-derived stromal cells to pulmonary alveoli protects against acute lung injury. Nat Med (2012) 3.47
Theoretical, empirical and practical approaches to resolving the unmet information needs of clinical information system users. Proc AMIA Symp (2002) 3.45
Role of HIV membrane in neutralization by two broadly neutralizing antibodies. Proc Natl Acad Sci U S A (2009) 3.19
Effectiveness of first eight methadone maintenance treatment clinics in China. AIDS (2007) 3.18
Novel role of PKR in inflammasome activation and HMGB1 release. Nature (2012) 3.13
Pseudomonas syringae effector AvrPto blocks innate immunity by targeting receptor kinases. Curr Biol (2007) 2.84
Scaling up the national methadone maintenance treatment program in China: achievements and challenges. Int J Epidemiol (2010) 2.65
Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease. FASEB J (2004) 2.56
Use of online resources while using a clinical information system. AMIA Annu Symp Proc (2003) 2.49
Association analyses identify six new psoriasis susceptibility loci in the Chinese population. Nat Genet (2010) 2.41
High mobility group box protein 1: an endogenous signal for dendritic cell maturation and Th1 polarization. J Immunol (2004) 2.32
IFN-gamma induces high mobility group box 1 protein release partly through a TNF-dependent mechanism. J Immunol (2003) 2.24
Factors influencing body composition in persons with spinal cord injury: a cross-sectional study. J Appl Physiol (1985) (2003) 2.23
Potent and selective inhibitors of the Met [hepatocyte growth factor/scatter factor (HGF/SF) receptor] tyrosine kinase block HGF/SF-induced tumor cell growth and invasion. Mol Cancer Ther (2003) 2.07
Analysis of polarity information in medical text. AMIA Annu Symp Proc (2005) 2.07
miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3. Mol Cancer Res (2011) 2.00
Inhibition of lymphocyte trafficking shields the brain against deleterious neuroinflammation after stroke. Brain (2011) 1.95
Abnormal neural activity in children with attention deficit hyperactivity disorder: a resting-state functional magnetic resonance imaging study. Neuroreport (2006) 1.92
HIF-1α and HIF-2α correlate with migration and invasion in gastric cancer. Cancer Biol Ther (2010) 1.83
Hyperthyroid-associated osteoporosis is exacerbated by the loss of TSH signaling. J Clin Invest (2012) 1.77
The phloem-delivered RNA pool contains small noncoding RNAs and interferes with translation. Plant Physiol (2009) 1.76
[The epidemic characteristics and preventive measures of hemorrhagic fever with syndromes in China]. Zhonghua Liu Xing Bing Xue Za Zhi (2004) 1.71
Circulating microRNAs in patients with active pulmonary tuberculosis. J Clin Microbiol (2011) 1.70
Fast and accurate search for non-coding RNA pseudoknot structures in genomes. Bioinformatics (2008) 1.69
Mitochondria to nucleus stress signaling: a distinctive mechanism of NFkappaB/Rel activation through calcineurin-mediated inactivation of IkappaBbeta. J Cell Biol (2003) 1.69
Genome-wide association study for vitiligo identifies susceptibility loci at 6q27 and the MHC. Nat Genet (2010) 1.69
Structure of a ternary transcription activation complex. Mol Cell (2004) 1.68
Thyroid-stimulating hormone induces a Wnt-dependent, feed-forward loop for osteoblastogenesis in embryonic stem cell cultures. Proc Natl Acad Sci U S A (2011) 1.67
Deubiquitinating and interferon antagonism activities of coronavirus papain-like proteases. J Virol (2010) 1.64
A molecular neuroanatomical study of the developing human neocortex from 8 to 17 postconceptional weeks revealing the early differentiation of the subplate and subventricular zone. Cereb Cortex (2007) 1.64
Follicle-stimulating hormone stimulates TNF production from immune cells to enhance osteoblast and osteoclast formation. Proc Natl Acad Sci U S A (2006) 1.64
Neuroimmunophilin ligands protect cavernous nerves after crush injury in the rat: new experimental paradigms. Eur Urol (2006) 1.63
Proteasome-dependent degradation of guanosine 5'-triphosphate cyclohydrolase I causes tetrahydrobiopterin deficiency in diabetes mellitus. Circulation (2007) 1.63
Smoking and obstructive lung dysfunction in persons with chronic spinal cord injury. J Spinal Cord Med (2003) 1.63
Impaired osteoblastic differentiation, reduced bone formation, and severe osteoporosis in noggin-overexpressing mice. J Clin Invest (2003) 1.63
Glucocerebrosidase gene-deficient mouse recapitulates Gaucher disease displaying cellular and molecular dysregulation beyond the macrophage. Proc Natl Acad Sci U S A (2010) 1.60
A cardiovascular drug rescues mice from lethal sepsis by selectively attenuating a late-acting proinflammatory mediator, high mobility group box 1. J Immunol (2007) 1.60
Loss of MMP-2 disrupts skeletal and craniofacial development and results in decreased bone mineralization, joint erosion and defects in osteoblast and osteoclast growth. Hum Mol Genet (2007) 1.56
Abnormal resting-state functional connectivity patterns of the putamen in medication-naïve children with attention deficit hyperactivity disorder. Brain Res (2009) 1.54
Smoke carcinogens cause bone loss through the aryl hydrocarbon receptor and induction of Cyp1 enzymes. Proc Natl Acad Sci U S A (2013) 1.54
Spermine protects mice against lethal sepsis partly by attenuating surrogate inflammatory markers. Mol Med (2009) 1.52
Medication reconciliation using natural language processing and controlled terminologies. Stud Health Technol Inform (2007) 1.51
Molecular regulation of mechanotransduction. Biochem Biophys Res Commun (2005) 1.51
Community-based trial to prevent drug use among youths in Yunnan, China. Am J Public Health (2002) 1.50
CA 125, PET alone, PET-CT, CT and MRI in diagnosing recurrent ovarian carcinoma: a systematic review and meta-analysis. Eur J Radiol (2008) 1.50
Transcarotid artery endovascular reconstruction of the aortic arch by modified bifurcated stent graft for Stanford type A dissection. Asian J Surg (2007) 1.49
Bacterial endotoxin stimulates macrophages to release HMGB1 partly through CD14- and TNF-dependent mechanisms. J Leukoc Biol (2004) 1.49
Body composition and mortality after adult lung transplantation in the United States. Am J Respir Crit Care Med (2014) 1.49
Hypoxia-inducible factor-1 alpha contributes to hypoxia-induced chemoresistance in gastric cancer. Cancer Sci (2007) 1.48
Intermittent recombinant TSH injections prevent ovariectomy-induced bone loss. Proc Natl Acad Sci U S A (2008) 1.46
Practical considerations for exploiting the World Wide Web to create infobuttons. Stud Health Technol Inform (2004) 1.45
Vertical ground reaction force-based analysis of powered exoskeleton-assisted walking in persons with motor-complete paraplegia. J Spinal Cord Med (2013) 1.44
Oxytocin is an anabolic bone hormone. Proc Natl Acad Sci U S A (2009) 1.44
Suppression of HMGB1 release by stearoyl lysophosphatidylcholine:an additional mechanism for its therapeutic effects in experimental sepsis. J Lipid Res (2005) 1.43
Cutting edge: high-mobility group box 1 preconditioning protects against liver ischemia-reperfusion injury. J Immunol (2006) 1.42
Knockdown of Adhesion-Regulating Molecule 1 Inhibits Proliferation in HL60 Cells. Acta Haematol (2015) 1.41
The bHLH transcription factor MYC3 interacts with the Jasmonate ZIM-domain proteins to mediate jasmonate response in Arabidopsis. Mol Plant (2011) 1.41
A brief HIV stigma reduction intervention for service providers in China. AIDS Patient Care STDS (2008) 1.41
EGCG stimulates autophagy and reduces cytoplasmic HMGB1 levels in endotoxin-stimulated macrophages. Biochem Pharmacol (2011) 1.41
Occupational cooking and risk of uveal melanoma: a meta-analysis. Asian Pac J Cancer Prev (2012) 1.40
Effect of indole-3-carbinol on ethanol-induced liver injury and acetaldehyde-stimulated hepatic stellate cells activation using precision-cut rat liver slices. Clin Exp Pharmacol Physiol (2010) 1.40
Over-expression of CKS1B activates both MEK/ERK and JAK/STAT3 signaling pathways and promotes myeloma cell drug-resistance. Oncotarget (2010) 1.40
Statistical research on marine natural products based on data obtained between 1985 and 2008. Mar Drugs (2011) 1.38
The aqueous extract of a popular herbal nutrient supplement, Angelica sinensis, protects mice against lethal endotoxemia and sepsis. J Nutr (2006) 1.38
The spectrum of systemic immune alterations after murine focal ischemia: immunodepression versus immunomodulation. Stroke (2009) 1.38
Metastasis-associated in colon cancer-1 upregulation predicts a poor prognosis of gastric cancer, and promotes tumor cell proliferation and invasion. Int J Cancer (2013) 1.38
Simultaneous determination of the size and surface charge of individual nanoparticles using a carbon nanotube-based Coulter counter. Anal Chem (2003) 1.37
First insights into the syntrophic acetate-oxidizing bacteria--a genetic study. Microbiologyopen (2012) 1.36
Osteoclast signalling pathways. Biochem Biophys Res Commun (2005) 1.36
AMP-activated protein kinase activation as a strategy for protecting vascular endothelial function. Clin Exp Pharmacol Physiol (2007) 1.35
Soluble invertase expression is an early target of drought stress during the critical, abortion-sensitive phase of young ovary development in maize. Plant Physiol (2002) 1.35
Orthogonal representation of sound dimensions in the primate midbrain. Nat Neurosci (2011) 1.35
A perspective on the muscle reflex: implications for congestive heart failure. J Appl Physiol (1985) (2005) 1.34
The resurgence of Coulter counting for analyzing nanoscale objects. Analyst (2004) 1.33
Thromboxane receptor activates the AMP-activated protein kinase in vascular smooth muscle cells via hydrogen peroxide. Circ Res (2007) 1.32
Effects of unilateral decompressive craniectomy on patients with unilateral acute post-traumatic brain swelling after severe traumatic brain injury. Crit Care (2009) 1.32
Genotype-phenotype correlation in 1,507 families with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency. Proc Natl Acad Sci U S A (2013) 1.31
Protein kinase Czeta-dependent LKB1 serine 428 phosphorylation increases LKB1 nucleus export and apoptosis in endothelial cells. J Biol Chem (2008) 1.31
JAK/STAT1 signaling promotes HMGB1 hyperacetylation and nuclear translocation. Proc Natl Acad Sci U S A (2014) 1.31